OTC / pharmaceutical oral-film capability
Simethicone Strips
Simethicone Strips are presented as an oral thin-film development concept for qualified product-development, regulatory and contract-manufacturing discussions.
Direct answer
What are Simethicone Strips?
Simethicone Strips are an oral thin-film development concept in which simethicone is evaluated for incorporation into a film placed in the mouth. Feasibility depends on the intended use, target amount per film, API grade and physical form, dispersion, content uniformity, film performance, packaging and destination-market regulatory pathway.
Product-development overview
Build control around a challenging dispersed active.
Development begins with the target product profile, intended population, use case, proposed label and market. Because simethicone is not treated like a freely soluble active, the programme must establish a robust dispersion strategy and connect it to film uniformity, mechanical properties, performance testing and stability.
- API grade, source, physical form and specification review
- Dispersion, film loading and content-uniformity development
- Film strength, disintegration and performance-method planning
- Flavour, mouthfeel and excipient-compatibility assessment
- Pilot, stability, process-control and packaging planning
Lagom pathway
A controlled development sequence.
- 01Define use, target profile and market
- 02Assess API, dispersion and regulatory feasibility
- 03Develop, analyse and evaluate prototypes
- 04Scale, validate, package and prepare supply
Buyer information
Simethicone Strips project facts
| Dosage format | OTC or pharmaceutical oral thin-film concept, subject to market classification |
|---|---|
| Manufacturing route | Feasibility-led; no commercial availability or approval implied |
| Typical project stages | Technical and regulatory feasibility, prototypes, analytical work, pilot, scale-up, stability and packaging |
| Manufacturer location | Hyderabad, Telangana, India |
| Commercial confirmation | Only after technical, quality, regulatory, facility and volume review |
Frequently asked questions
Questions qualified buyers ask
Can Lagom contract manufacture Simethicone Strips?
Lagom can review a qualified product brief. Any development or manufacturing route requires confirmation of API source and grade, intended use, target amount, population, destination market, regulatory strategy, analytical requirements, facility fit, forecast volume and client responsibilities.
Is a simethicone oral film automatically equivalent to a chewable tablet or liquid?
No. Strength, delivery performance, label directions, evidence requirements and equivalence cannot be assumed across dosage forms. The proposed film requires its own technical and market-specific regulatory assessment.
How should intended use and labelling be handled?
Current U.S. OTC labels identify simethicone as an anti-gas active for relief of pressure, bloating and fullness commonly referred to as gas. A proposed oral film must follow the rules and approved wording applicable to its own destination market; this capability page is not consumer labelling or medical advice.
What information is needed for a proposal?
Share the destination market, intended use and population, API grade and source, target amount per film, reference product or development basis, proposed claims, pack format, forecast volume and timeline.
Professional-use notice: This B2B page is for qualified development discussions and is not patient information or medical advice. Technical, clinical, safety, regulatory and commercial details require project-specific review.
Start a qualified discussion
Planning a simethicone oral-film programme?
Share the intended use, target amount, development basis, destination market and expected volume.